chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from an online article. On unknown dates, numerous people (demographics not provided) were vaccinated with ZOSTAVAX (lot numbers, dosages and routes of administration not provided). It was noted that the ZOSTAVAX vaccine to prevent varicella, the adult version of chickenpox was causing numerous people who got the shot to suffer injuries and/or death. The causes of death were not provided. It is unknown if autopsies were performed. It was alleged that the vaccine for shingles wasn't safe and could cause serious adverse effects. It was reported that patient injuries from the ZOSTAVAX ranged from shingles itself, which the vaccine was supposed to prevent, to serious personal injuries such as blindness and paralysis. Other reports of adverse effects from ZOSTAVAX included brain damage and death. "But the thousands of people who took the shot [ZOSTAVAX] and are now permanently injured or dead...." According to data compiled by a law firm, ZOSTAVAX "is only effective in about 51% of people who get the shot. And many of those who receive the [ZOSTAVAX] vaccine end up getting shingles anyway." "There is some indication that the vaccination is linked to death." "The NCIS (The National Vaccine Information Center) analysis indicates that there were more than 1,100 serious adverse event reports made to the Vaccine Adverse Events Reporting System from 1990 until September 2015 related to shingles-containing vaccinations. Of these reports, 90 were for deaths associated with the shingles vaccine." The outcome of injuries and/or death is fatal, and the outcome of the blindness, paralysis, brain damage, and shingles is unknown. Upon internal review, injuries and/or death, blindness, paralysis, and brain damage were determined to be medically significant. Blindness, paralysis, brain damage, and shingles were considered to be disabling. Additional information is not expected.; Reported Cause(s) of Death: Death.
Constant ringing of both ears, head buzzing loudly, vision blurry. Ongoing
minor vertigo--lasted about 18 hours. Reported to primary care physician the following morning (spoke to PA, did not visit the office). It was gone by afternoon. No treatment.
Headache, Myalgia, Diarrhea, NauseaVomiting, Localized itching, pain; fatigue Narrative:
Received a vaccine that underwent a temperature excursion; No adverse event; Received a vaccine that underwent a temperature excursion; This spontaneous case was reported by a medical assistant and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Received a vaccine that underwent a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Received a vaccine that underwent a temperature excursion) and NO ADVERSE EVENT (No adverse event) in a 3-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1412B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Aug-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Received a vaccine that underwent a temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Received a vaccine that underwent a temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Received a vaccine that underwent a temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Received a vaccine that underwent a temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Received a vaccine that underwent a temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Received a vaccine that underwent a temperature excursion).    Weight of the patient was reported as 18#14 oz was reported.  No concomitant medication was reported by reporter.  The patient had Moderna administration location on LQ (unspecified).  Some vaccines were stored in the freezer and other vials in the refrigerator. The excursion occurred on 7-Aug-2022 and was picked up by state review of the temperature data logger 2 weeks later after the excursion. Total 38 patients received this.  1 refrigerated vial was  with lot number AS1412B and expiration date 10-Feb-2023. Maximum or minimum temperatures reached was 14 degrees Celsius for 3hr 5min. Vial was moved from refrigerator on 8-Aug-2022. Those were administered or discarded. Proposed desired used by date was 18-Aug-2022.  No treatment medication was reported by reporter.
MILD HEADACHE FROM SCALE 1-10 SEVERITY 3; This spontaneous report received from a patient concerned a 64 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included sulpha allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and  expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 18:30 for prophylactic vaccination at left arm. No concomitant medications were reported. On 20-MAR-2021, the subject experienced mild headache from scale 1-10 severity 3. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from mild headache from scale 1-10 severity 3. This report was non-serious.
The patient started having symptoms of back pain that radiated up her spine.  He says it started the following day after receiving the vaccine.  She also started she had pain in her veins in her hands.
extreme fatigue, sore arms-aching-some nausea & diarrhea w/48 hrs; rash 1 wk later (raised fine on chess & arms; lower back pain; 25MAy still has soreness in arms, rash & feels tired;
Patient has called to inform us (4 months after immunization) that she is having pain and reduced mobility in her shoulder, beginning shortly after being immunized.
Numbness to face, 166/90, HR 83, O2Sat 90. Pt. stated that she was feeling better.  Recommended to contact 911 or Primary Care Doctor if still having symptoms, Understanding verbalized.
alot of chest pain (lt side only); soreness under armpit & down lt arm; groin area feels bruised; very tired/lot of back pain (middle back);
had a reaction to the cat/symptoms started within a couple of days after it was with the cat; trouble breathing; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO ANIMAL (had a reaction to the cat/symptoms started within a couple of days after it was with the cat) and DYSPNOEA (trouble breathing) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Allergic to cats. Concomitant products included METHYLPREDNISOLONE ACETATE (DEPOMEDROL) for Allergy.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced ALLERGY TO ANIMAL (had a reaction to the cat/symptoms started within a couple of days after it was with the cat) and DYSPNOEA (trouble breathing). The patient was treated with OLOPATADINE HYDROCHLORIDE (ALLERCHECK) for Adverse event, at a dose of 1 dosage form and TRIAMCINOLONE ACETONIDE (NASACORT) for Adverse event, at a dose of 1 dosage form. At the time of the report, ALLERGY TO ANIMAL (had a reaction to the cat/symptoms started within a couple of days after it was with the cat) and DYSPNOEA (trouble breathing) outcome was unknown.            The Patient stated on June travelled again and took the Depometrol and that time had it one week before and could stay with the cat.The patient said it's doctor told them that possibly travelled before the Deprometrol on Feb 10th acted the patient also stated that the it was a reaction to the cat because it was on lockdown and quarantine with the cat for 5 days   This case was linked to MOD-2021-335196 (Patient Link).
This spontaneous report received from a pharmacist referred to a 67-year old male patient. The patient's pertinent medical history included arthritis. Concurrent conditions included pain in the right hip. Concomitant medications included Atorvastatin (manufacturer unknown), tamsulosin (manufacturer unknown), omeprazole (manufacturer unknown) and an unspecified multivitamin. Approximately on an unknown date in September 2016 (reported as one month ago), the patient saw a healthcare provider because he had been experiencing pain in right hip. The pain had been occurring for 3 weeks prior to his appointment The healthcare provider recommended steroid therapy but the patient declined receiving it. However during the same appointment, the patient received a dose of ZOSTAVAX (Dose, frequency, lot number and expiry date were not reported). Since then the patient's hip pain got worse. On an unknown date in September 2016, the patient was walking funny (Gait disturbance) because of the pain. The patient had been treating himself with ibuprofen. The patient would probably be starting steroid therapy soon on an unspecified date. The pharmacist stated that the worsening of hip pain has nothing to do with ZOSTAVAX. Outcome of the events was not reported. Causality of worsening of hip pain was reported as not related. Causality of Gait disturbance was not reported. Additional information has been requested.
Low fever started 12 hours after second dose, lasted for 12 hours.; Dizziness started 24 hours after second dose, lasted 2 hours; This is a spontaneous report from a Non-contactable Other Health Professional reported for a female patient. A 25-year-old adult non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: unknown), dose 2 via an intramuscular route of administration, administered in Arm Left on 10Feb2021 at 12:00 PM (at the age of 25-year-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient other medical history was none. The patient had no known allergies. The patient had no covid prior to vaccination. The patient concomitant medications were not reported. The patient previously received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: unknown), via an intramuscular route of administration, administered in Arm Left on 20Jan2021 at 09:15 AM (at the age of 25-year-old) as single dose for covid-19 immunisation and experienced Prolonged and heavier menstrual cycle after first dose on 21Jan2021. No other vaccine in four weeks. No other medications in two weeks. The patient had not been tested for covid post vaccination. On 11Feb2021, the patient experienced low fever which started 12 hours after second dose and lasted for 12 hours and Dizziness, which started 24 hours after second dose and lasted for 2 hours. No treatment was received to treat the events. The patient outcome of the events was Resolved on an unspecified date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Prevnar 13 was given instead of prevnar 23. Provider entered vaccine order in chart correctly, but MA did not do proper team check prior to giving and did not document in real time. Error was found after administering Prevnar 13. Patient was called and informed. No reaction or adverse side effects.
Fatigue Tired Muscle weakness Took the vaccine vaccine at 2:20pm felt the symptoms at 4:45 pm I passed out and woke up at 5:45am
Immediate stinging, itching, swelling and redness at injection site, and covering entire deltoid area, axillary area and half of left breast.  Heache and nausea, coughing and nasal congestion with clear drainage.  To date, Heache, cough, dizziness, fatigue and muscle pain still persist.
pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site). At the time of the report, VACCINATION SITE PAIN (pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Left arm pain which started shortly after the injection and has continued since, which is 8 days after.  The pain got significantly worse within the first 24 hours, has decreased slightly but still present.  The pain is worse with movement of the arm.  There was no redness, swelling or abscess.  She is being treated with ibuprofen and norco and will follow up in 3 days.
shot was given too high and patient was experiencing pain in the shoulder. Pain is getting better but remained on 10/25/2021
Time between 1st and 2nd dose was 2 weeks; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Time between 1st and 2nd dose was 2 weeks) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Arthritis and Thyroiditis. Concomitant products included ATENOLOL for Blood pressure management.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Time between 1st and 2nd dose was 2 weeks). In April 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Time between 1st and 2nd dose was 2 weeks) had resolved.            Other concomitant medication includes  Arthritis medication, Statin and Thyroid medication. No treatment medications were reported.   This case was linked to MOD-2022-437601 (Patient Link).
Subsequent to receiving one dose of varicella virus vaccine live, the pt experienced a rash on her torso. The pt also had a low grade fever and was itching one day post onset.  The physician noted approximately 30 bumps all over her body. On 11/22/99, the pt developed a headache and uncharacteristically slept for 12 hours. The pt developed a red throat. The physician did not dx chickenpox because all the bumps looked the same. Follow up information indicated that the pt experienced a mild case of varicella. Additional information has been requested.
Very swollen leg, knee and buttock for several days - treatment: Prednisolone and antibiotic, Benadryl and Motrin.
I developed a lump on the inside of my left elbow. I went to the doctor and they stuck some needles on it to see if it was something that could be drained. It was not. They did an MRI on it, they said it was nothing to worry about but if it bothers me they could cut it out.
patient received an expired dose of Adacel with no reported adverse event; Initial information received on 09-Dec-2021 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (healthcare professional).  This case involves a 22-years-old male patient who received an expired dose of adacel with no reported adverse event while receiving vaccine diphtheria-2/tetanus/5 ac pertussis vaccine [Adacel].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 09-Mar-2022, the patient received a dose of 0.5 mL of suspect diphtheria-2/tetanus/5 ac pertussis vaccine Suspension for injection once  (lot U5872AA/:06984AA; 02-Feb-2022 and 18-Mar-2023) via intramuscular route in the right deltoid as prophylactic vaccination.  On 09-MAR-2022 the patient developed a non-serious event "patient received an expired dose of adacel with no reported adverse event" (expired product administered) (latency: same day) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Action taken: Not applicable.  Corrective treatment: Not reported  Outcome: Unknown for expired product administered.  Additional information was received on 09-Mar-2022 from consumer/non-hcp: Case updated to non-serious case from non-case.
Felt as if he had a bad sunburn all over the body, had a fever, on injection site had a raised welt approximately 5?s in width and 14 or more in length, all over the same arm looked as if he had needle pin pricks,  intense headache stated his brain felt like it was going to explode, cotton mouth, insatiable thirst, drank huge amounts of water non stop, did not eat,  had horrible joint pain,  at one point unable to walk and loss control of his bowels, BP was elevated, pulse was elevated, hard time speaking,  did not sleep for 6/7 days, unable to focus or concentrate, heard voices & music,  was paranoid,  was talking erratically, thought people were in the room when they were not, had no sense of reality,  toenails were falling off
Pain and swelling were reported by a friend of the pt a day after vaccine was administered. A few days later Dr. office reported fluid had to be drained from the shoulder due to swelling.
Pt was transferred from one SNF to another SNF prior to admission to hospital.  There was no flag or medical records information about the Moderna vaccine given at SNF on 12 May 2021 in the patient's SNF records.  Pt stated she got 'shots or vaccines' but could not specificy date or name.  She had no immediate reaction or adverse events after the Pfizer vaccines on 6 July or 5 August 2021.
she received Pfizer booster shot on yesturday; she received Pfizer booster shot on yesturday; sore arm; This is a spontaneous report received from a contactable consumer or other non hcp. A 81-years-old female patient received 3rd dose of bnt162b2 (Pfizer COVID-19 vaccine,Batch/Lot number was not reported), via an unspecified route of administration on 23Sep2021,at the age of 81 years old, as Dose 3 (Booster),single for covid-19 immunization and palbociclib (IBRANCE), via an unspecified route of administration from an unspecified date to an unspecified date, at 100 mg for an unspecified indication.The patient medical history was not reported.Concomitant medication(s) included exemestane (AROMASIN) taken for an unspecified indication, start and stop date were not reported. The patient experienced sore arm on Sep2021, she received pfizer booster shot on yesterday on 23Sep2021.The outcome of the event was unknown.The patient didn't receive any treatment for the event.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up. Follow up (24Sep2021): This is a follow up spontaneous report received from a contactable consumer. A contactable 81-year-old Female consumer (patient) reported for herself that she experienced side effects with ibrance.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
chills and fever the night off, tired, the day after her armpit of the arm she was vaccinated in is red and swollen, it is painful,
Booster; Are there active trials for people who are fully vaccinated plus boosted and have contracted COVID-19; Are there active trials for people who are fully vaccinated plus boosted and have contracted COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "Booster"; DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Are there active trials for people who are fully vaccinated plus boosted and have contracted COVID-19".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Evening of immunization,pt broke out in an all over itch.No rash seen until 11/22 pm;described as sandpaper feeling rash all over body.Saw MD on 11/30.
Patient had received the first dose on 9/14/21 at a different location for Moderna, which was a mistake from the beginning due to patient's age of 17 years. She received the 2nd dose at our store for Pfizer dose because of her age at time vaccine was given.
Progressive chest tightness, chest pain relieved with leaning forward, pain with use of left (injection) arm, radiating pain up and down the left chest, left arm, and left jaw.
Extreme Vertigo started aprox 1 and 1/2 days after vaccine, bad for a couple days, lasted for about 1 week. Per pt symptoms tapered off in about 1 week time and resolved.
Occured 20 hours after the shot and lasted for 11 hours. Cold sweats. Headache. No appetite. Sluggishness. Overall felt awful
TESTED POSITIVE FOR COVID-19; This spontaneous report received from a consumer concerned a 43 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug usage.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: 23-AUG-2021) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 30-JUL-2021, the subject experienced tested positive for covid-19. Laboratory data included: COVID-19 virus test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tested positive for covid-19. This report was non-serious. This report was associated with product quality complaint: 90000187968.; Sender's Comments: V0: Medical assessment comments not required as per standard procedure as the case is considered non serious.
About 4 hours after injection my left arm muscle started to be very sore and stiff.  Assumed it was a normal short lasting side effect. Progressively continued to get worse. Pain and muscle weakness along with loss of arm mobility eventually caused me to go to Urgent care after 2.5 weeks of worsening pain. Had tried ice/heat/rest and over the counter pain medication prior to visit with no relief.
This spontaneous report was received from a physician via a company representative concerning to a patient of unknown age and gender. No concurrent conditions, medical history or concomitant medication were reported. On 14-AUG-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 with lot # L007720 Expiration date: 08-JUL-2016, 0.5 ml (route and anatomical location of administration were not reported). The sum of hours in excursion was 72 hours and the lowest recorded temperature reported was 33 Fahrenheit (F) (0.555555556 Celsius(C)). The storage criteria and the storage type were reported as "Refrigerator(R)". The vaccine status was reported as "in excursion". No adverse effects were reported nor Product Quality Complaint (PQC) involved. This is one of several cases received from the same reporter. Additional information has been requested.